Oramed Pharma
(ORMP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2011 | 08-2011 | 12-2010 | 12-2006 | |
| Operating Expenses | 1,203 | 2,435 | 1,276 | 0 |
| Operating Income | -1,203 | -2,435 | -1,276 | N/A |
| Interest Expense | 0 | 19 | 19 | 0 |
| Other Income | -171 | 869 | -290 | 0 |
| Pre-tax Income | -1,374 | -1,585 | -1,585 | 0 |
| Income Tax | N/A | -24 | -24 | N/A |
| Net Income Continuous | -1,374 | -1,561 | -1,561 | N/A |
| Net Income | $-3,344 | $-1,561 | $-1,561 | $N/A |
| EPS Basic Total Ops | N/A | -0.02 | N/A | N/A |
| EPS Basic Continuous Ops | N/A | -0.02 | N/A | N/A |
| EPS Diluted Total Ops | N/A | -0.02 | N/A | N/A |
| EPS Diluted Continuous Ops | N/A | -0.02 | N/A | N/A |
| EBITDA(a) | $-1,197 | $-2,407 | $-1,269 | $N/A |